Palsonify

Active Ingredient(s): Paltusotine
FDA Approved: * September 25, 2025
Pharm Company: * CRINETICS PHARMA INC
Category: Acromegaly
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Palsonify 20 mg Oral Tablet, Film Coated
NDC: 84015-920
Labeler:
Crinetics Pharmaceuticals, Inc.
Palsonify 30 mg Oral Tablet, Film Coated
NDC: 84015-930
Labeler:
Crinetics Pharmaceuticals, Inc.